Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that it will be participating in the BTIG Snowbird Conference taking place on Monday, February 12 through Wednesday, February 14, 2024 in Snowbird. Shantanu Gaur, Allurion’s Chief Executive Officer, and Chris Geberth, Chief Financial Officer, will be available for investor 1x1 meetings.

About Allurion

Allurion is dedicated to ending obesity. The Allurion Program is a weight-loss platform that combines the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-less gastric balloon for weight loss, the Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale and Health Tracker devices. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor, and manage weight-loss therapy for patients regardless of their treatment plan, whether it is gastric balloon, surgical, medical or nutritional. The Allurion Gastric Balloon is an investigational device in the United States.

For more information about Allurion and the Allurion Virtual Care Suite, please visit www.allurion.com.

US Media Brian Ruby ICR 203-682-8268 brian.ruby@icrinc.com Global Media Cedric Damour PR Manager +33 7 84 21 02 20 cdamour@allurion.com Investors Mike Cavanaugh ICR Westwicke 617-877-9641 mike.cavanaugh@westwicke.com

Grafico Azioni Allurion Technologies (NYSE:ALUR)
Storico
Da Mag 2024 a Giu 2024 Clicca qui per i Grafici di Allurion Technologies
Grafico Azioni Allurion Technologies (NYSE:ALUR)
Storico
Da Giu 2023 a Giu 2024 Clicca qui per i Grafici di Allurion Technologies